Rfg Advisory, LLC Merck & Co., Inc. Transaction History

Rfg Advisory, LLC

$3.18 Billion
Q3 2024

A detailed history of Rfg Advisory, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rfg Advisory, LLC holds 42,490 shares of MRK stock, worth $4.22 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

42,490

Previous 48,715 12.78%

Holding current value

$4.22 Million

Previous $6.03 Million 19.98%

% of portfolio

0.15%

Previous 0.2%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$111.15 - $128.97 $691,908 - $802,838	-6,225 Reduced 12.78%	42,490 $4.83 Million
Q2 2024 Jul 15, 2024	BUY	$123.8 - $132.96 $1.33 Million - $1.43 Million	10,746 Added 28.3%	48,715 $6.03 Million
Q1 2024 Apr 11, 2024	SELL	$113.24 - $131.95 $117,656 - $137,096	-1,039 Reduced 2.66%	37,969 $5.01 Million
Q4 2023 Jan 25, 2024	SELL	$100.18 - $109.02 $146,964 - $159,932	-1,467 Reduced 3.62%	39,008 $4.25 Million
Q3 2023 Oct 16, 2023	BUY	$102.95 - $114.33 $551,812 - $612,808	5,360 Added 15.26%	40,475 $4.17 Million
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $134,893 - $147,027	-1,242 Reduced 3.42%	35,115 $4.05 Million
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $53,528 - $59,727	-520 Reduced 1.41%	36,357 $3.87 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $33,576 - $43,050	-384 Reduced 1.03%	36,877 $4.09 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $267,875 - $300,928	3,169 Added 9.3%	37,261 $3.78 Million
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $1.1 Million - $1.25 Million	13,181 Added 63.03%	34,092 $2.98 Million
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $2,940 - $3,296	-40 Reduced 0.19%	20,911 $1.72 Million
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $39,537 - $49,525	547 Added 2.68%	20,951 $1.61 Million
Q3 2021 Oct 19, 2021	BUY	$71.68 - $78.83 $439,326 - $483,149	6,129 Added 42.94%	20,404 $1.53 Million
Q2 2021 Jul 29, 2021	SELL	$70.31 - $77.77 $54,349 - $60,116	-773 Reduced 5.14%	14,275 $1.11 Million
Q1 2021 Apr 19, 2021	SELL	$68.86 - $81.11 $21,553 - $25,387	-313 Reduced 2.04%	15,048 $1.16 Million
Q4 2020 Feb 02, 2021	SELL	$71.77 - $79.65 $115,908 - $128,634	-1,615 Reduced 9.51%	15,361 $1.28 Million
Q3 2020 Oct 13, 2020	BUY	$73.18 - $82.95 $6,952 - $7,880	95 Added 0.56%	16,976 $1.41 Million
Q2 2020 Aug 03, 2020	BUY	$70.42 - $80.13 $115,911 - $131,893	1,646 Added 10.8%	16,881 $1.31 Million
Q1 2020 Apr 17, 2020	BUY	$63.36 - $87.82 $68,745 - $95,284	1,085 Added 7.67%	15,235 $1.17 Million
Q4 2019 Jan 22, 2020	BUY	$77.58 - $87.54 $197,053 - $222,351	2,540 Added 21.88%	14,150 $1.29 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $42,756 - $46,606	562 Added 5.09%	11,610 $977,000
Q2 2019 Aug 23, 2019	BUY	$69.84 - $81.59 $330,762 - $386,410	4,736 Added 75.03%	11,048 $927,000
Q2 2019 Aug 15, 2019	BUY	$69.84 - $81.59 $32,475 - $37,939	465 Added 7.95%	6,312 $531,000
Q1 2019 Apr 25, 2019	BUY	$69.58 - $79.36 $13,637 - $15,554	196 Added 3.47%	5,847 $487,000
Q4 2018 Feb 15, 2019	SELL	$65.24 - $75.71 $93,684 - $108,719	-1,436 Reduced 20.26%	5,651 $432,000
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $80,996 - $95,247	1,404 Added 24.71%	7,087 $560,000
Q2 2018 Jul 25, 2018	SELL	$50.83 - $59.72 $431,750 - $507,261	-8,494 Reduced 59.91%	5,683 $345,000
Q1 2018 May 10, 2018	SELL	$50.96 - $59.23 $21,658 - $25,172	-425 Reduced 2.91%	14,177 $772,000
Q4 2017 Feb 08, 2018	BUY	$51.62 - $61.64 $62,976 - $75,200	1,220 Added 9.12%	14,602 $827,000
Q3 2017 Nov 02, 2017	SELL	$58.67 - $63.13 $22,763 - $24,494	-388 Reduced 2.82%	13,382 $861,000
Q2 2017 Nov 01, 2017	SELL	N/A	-194 Reduced 1.39%	13,770 $866,000
Q2 2017 Aug 14, 2017	SELL	N/A	-97 Reduced 0.69%	13,964 $878,000
Q1 2017 Nov 01, 2017	BUY	N/A	5,865 Added 71.56%	14,061 $894,000
Q4 2016 Nov 01, 2017	BUY	N/A	8,196	8,196 $512,000

Others Institutions Holding MRK

# of Institutions

3,829

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.

Account